GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits

GlaxoSmithKline managed to notch some wins during the pandemic-challenged year of 2020, but COVID-19 took its toll—not only on the British pharma's finances, but on CEO Emma Walmsley’s pay, too.